← Leaderboards
Bing-Hua Jiang
Scripps Research Institute
$8,039,089
Attributed
$9,077,604
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$9,077,604 · 11
By mechanism
R01$7,756,801 · 6
R21$787,268 · 2
P20$362,733 · 1
R03$144,376 · 1
F32$26,426 · 1
Top collaborators
- Ling-Zhi Liu3 shared
- Stephen C Peiper2 shared
Others in their field
Top investigators on “Angiogenesis”
- David Heimbrook · Leidos Biomedical Research, Inc.$75,067,502
- Steven Terry Rosen · Beckman Research Institute/City Of Hope$59,567,306
- Martin Friedlander · Scripps Research Institute$48,350,175
- Larry Arthur$33,866,306
- Michael Simons · Yale University$30,647,106
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$29,372,588
Research focus
AngiogenesisSignal TransductionFutureTumor GrowthMolecularTumorCellsVascular Endothelial Growth FactorsTumor AngiogenesisSignal PathwayParacrineEndothelial CellsMediatingIn VivoLungMalignant NeoplasmsReactive Oxygen SpeciesCancer CellAffectSignaling MoleculeEpithelial CellsOxidative StressProductionPlay
Grant awards (38)
Mechanism of lung cancer resistance to tyrosine kinase inhibitor and radiation treatments$569,617
R01 · FY2020 · CA · contact PI
Chromium in carcinogenesis and angiogenesis$307,764
R01 · FY2020 · ES · contact PI
Chromium in carcinogenesis and angiogenesis$1
R01 · FY2020 · ES · contact PI
Mechanism of lung cancer resistance to tyrosine kinase inhibitor and radiation treatments$552,528
R01 · FY2019 · CA · contact PI
Chromium in carcinogenesis and angiogenesis$307,765
R01 · FY2019 · ES · contact PI
NOX4 Mediates Oxidative Stress in Ovarian Tumor growth and treatment Response$305,098
R01 · FY2019 · CA · contact PI
Mechanism of lung cancer resistance to tyrosine kinase inhibitor and radiation treatments$582,742
R01 · FY2018 · CA · contact PI
Molecular Mechanism of Arsenic Carcinogenesis$331,257
R01 · FY2018 · ES · contact PI
NOX4 Mediates Oxidative Stress in Ovarian Tumor growth and treatment Response$321,204
R01 · FY2018 · CA · contact PI
Chromium in carcinogenesis and angiogenesis$320,890
R01 · FY2018 · ES · contact PI
Molecular Mechanism of Arsenic Carcinogenesis$329,418
R01 · FY2017 · ES · contact PI
NOX4 Mediates Oxidative Stress in Ovarian Tumor growth and treatment Response$250,878
R01 · FY2017 · CA · contact PI
NOX4 mediates oxidative stress in ovarian tumor growth and treatment response$105,972
R01 · FY2017 · CA · contact PI
NOX4 mediates oxidative stress in ovarian tumor growth and treatment response$356,850
R01 · FY2016 · CA · contact PI
Molecular Mechanism of Arsenic Carcinogenesis$329,418
R01 · FY2016 · ES · contact PI
Molecular Mechanism of Arsenic Carcinogenesis$40,129
R01 · FY2016 · ES · contact PI
Molecular Mechanism of Arsenic Carcinogenesis$333,819
R01 · FY2015 · ES · contact PI
Reactive Oxygen Species-Induced CXCL8 in Ovarian Cancer$169,650
R21 · FY2015 · CA
Molecular Mechanism of Arsenic Carcinogenesis$336,567
R01 · FY2014 · ES · contact PI
Reactive Oxygen Species-Induced CXCL8 in Ovarian Cancer$202,493
R21 · FY2014 · CA
WC-Co nanoparticles in initiating angiogenesis by reactive oxygen species$407,396
R01 · FY2010 · HL · contact PI
Analysis of arsenic in inducing ROS, signaling pathways, and lung carcinogenesis$232,000
R21 · FY2010 · ES · contact PI
PI3K Pathway in Prostate Tumorigenesis and Angiogenesis$227,246
R01 · FY2010 · CA · contact PI
WC-Co nanoparticles in initiating angiogenesis by reactive oxygen species$424,850
R01 · FY2009 · HL · contact PI
PI3K Pathway in Prostate Tumorigenesis and Angiogenesis$227,246
R01 · FY2009 · CA · contact PI
Analysis of arsenic in inducing ROS, signaling pathways, and lung carcinogenesis$183,125
R21 · FY2009 · ES · contact PI
PI3K Pathway in Prostate Tumorigenesis and Angiogenesis$40,823
R01 · FY2009 · CA · contact PI
PI3K Pathway in Prostate Tumorigenesis and Angiogenesis$22,172
R01 · FY2009 · CA · contact PI
PI3K Pathway in Prostate Tumorigenesis and Angiogenesis$227,246
R01 · FY2008 · CA · contact PI
PI3K Pathway in Prostate Tumorigenesis and Angiogenesis$263,871
R01 · FY2007 · CA · contact PI
Analysis of Apigenin in Inhibiting Ovarian Tumorigenesis$71,126
R03 · FY2007 · CA · contact PI
PI3K Pathway in Prostate Tumorigenesis and Angiogenesis$234,034
R01 · FY2006 · CA · contact PI
Analysis of Apigenin in Inhibiting Ovarian Tumorigenesis$73,250
R03 · FY2006 · CA · contact PI
COBRE: WVU: MECHANISM OF PI 3 KINASE INDUCED ANGIOGENESIS IN VIVO CANCER$72,686
P20 · FY2005 · RR
COBRE: WVU: MECHANISM OF PI 3 KINASE INDUCED ANGIOGENESIS IN VIVO CANCER$290,047
P20 · FY2004 · RR
MECHANISM OF PI3 KINASE INDUCED ANGIOGENESIS$0
P20 · FY2002 · RR
MECHANISM OF PI3 KINASE INDUCED ANGIOGENESIS$0
P20 · FY2001 · RR
ONCOGENES P3K AND AKT IN TUMORIGENESIS$26,426
F32 · FY2000 · CA